Healthcare -
Biotechnology - NASDAQ - US
$ 1.95
0 %
$ 409 M
Market Cap
-1.26
P/E
ALLO - TOTAL CURRENT ASSETS
Total Current Assets ALLO - Allogene Therapeutics, Inc.
459 M
LAST VALUE
-24.69%
2 YEAR CAGR
-0.38%
5 YEAR CAGR
0.00%
10 YEAR CAGR